Press Releases

Press Releases

Boehringer Ingelheim, one of the world’s leading biopharmaceutical companies, is now launching use of innovoPOINT® 6.6 by InnovoCommerce to enable the entire enterprise to streamline and digitize study start up, conduct and the close out processes. Boehringer Ingelheim selected the innovoPOINT solution in 2011 as part of the Cornerstone initiative—a…

Press Releases

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax™. The…

Press Releases

BioSyent Inc. announced today that its subsidiary BioSyent Pharma Inc. has signed an agreement with Photocure ASA granting BioSyent the exclusive rights for Cysview(R) in Canada. Cysview(R) (hexaminolevulinate hydro-chloride) is an innovative technology that aids in the diagnosis and management of bladder cancer and was approved by Health Canada in…

Press Releases

GTCR, a leading private equity firm, announced that it has completed the previously announced sale of its portfolio company Cord Blood Registry (“CBR” or the “Company”) to AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company that focuses on maternal health and hematology, for $700 million. Founded in 1992, CBR…

Press Releases

Polydex Pharmaceuticals Limited will be holding its Annual General Meeting at 10:00 am, local time, on August 28, 2015, at the principal offices of the Company located at 421 Comstock Road, Toronto, Ontario, Canada, M1L 2H5. The Company has previously announced the inaugural use of online voting and encourages registered…

Press Releases

Tivorsan Pharmaceuticals, Inc., a biotechnology company pioneering a novel approach to treating Duchenne Muscular Dystrophy and other serious neuromuscular disorders, today announced that James E. Connolly has joined the company as Chief Executive Officer (CEO) and a member of the Board. Connolly is an accomplished business executive with more than…

Press Releases

Merck, known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical research collaboration to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel…

Press Releases

HiFiBiO SAS announced today the company has achieved a milestone in its research collaboration with Pfizer Inc., triggering a milestone payment to HiFiBiO. The focus of the collaboration, originally signed in 2014, is the development and validation of HiFiBiO’s proprietary, high throughput antibody discovery platform for deep mining of immune…

Press Releases

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate™ system to a medical center located in Peru. The IOPtiMate™ system is based on CO2 laser technology that enables the performance of…

Friday, Aug 14, 2015
Press Releases

Adam Smith Conferences’ Clinical Trials in Russia forum will (24 – 26 November, Moscow) is the strategic meeting place for the sector's professionals and the only event to cover the entire clinical trials sector in Russia NEW in the programme! •    Discussion of key factors and tools in the work…